- 1st product approval in China represents Amneal’s entry in second largest pharmaceutical market- Expects international expansion will be another key vector for long-term growth and impactBRIDGEWATER, N.J. (BUSINESS WIRE) Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (“Amneal” or the “Company”) today announced it has.
AMR also known as antimicrobial drug resistance, occurs when microorganisms such as bacteria, fungi etc. change in such a way that the medications used to treat infections they cause are rendered ineffective.
Mumbai: Amneal Pharmaceuticals, Inc., has announced the launch of its commercial operations in India. To helm its India Commercial operations, Amneal has appointed Mr. Shyamakant Giri as Managing.
Mumbai: Amneal Pharmaceuticals, Inc. (NYSE: AMRX) (Amneal), launches its commercial operations in India. To helm its India Commercial operations, Amneal has appointed Mr. Shyamakant Giri as Managing Director and President, India Business and Emerging Markets. Mr. Giri has over two decades of experience leading business divisions and strategic operations of leading Indian and